Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism

Cell

Volumn 86, Issue 4, 1996, Pages 577-587

  Mohammadi, Moosa ^a   Schlessinger, Joseph ^a   Hubbard, Stevan R ^a,b  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; FIBROBLAST GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE;

ARTICLE; AUTOPHOSPHORYLATION; CRYSTAL STRUCTURE; DEVELOPMENTAL DISORDER; ENZYME BINDING; ENZYME PHOSPHORYLATION; ENZYME STRUCTURE; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR BINDING; STRUCTURE ANALYSIS;

NEMATODA;

EID: 0030598848     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)80131-2     Document Type: Article

References (37)

1. Basilico, C., and Moscatelli, D. (1992). The FGF family of growth factors and oncogenes. Adv. Cancer Res. 59, 115-165.
2. Bellus, G.A., McIntosh, I., Smith, E.A., Aylsworth, A.S., Kaitila, I., Norton, W.A., Greenhaw, G.A., Hecht, J.T., and Francomano, C.A. (1995). A recurrent mutation in thetyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia. Nature Genet. 10, 357-359.
3. 2+ adenylyl imidodiphosphate and inhibitor peptide PKl(5-24). EMBO J. 12, 849-859.
4. Brünger, A.T. (1992). X-PLOR (Version 3.1) Manual (New Haven, Connecticut: The Howard Hughes Medical Institute and Department of Molecular Biophysics and Biochemistry, Yale University).
5. Cantley, L.C., Auger, K.R., Carpenter, C., Duckworth, B., Graziani, A., Kapeller, R., and Soltoff, S. (1991). Oncogenes and signal transduction. Cell 64, 281-302.
6. Carson, M. (1991). Ribbons 2.0. J. Appl. Cryst. 24, 958-961.
7. Cowtan, K. (1994). Joint CCP4 and ESF-EACBM Newsletter on Protein Crystallography 31, 34-38.
8. DeVore, D.L., Horvitz, H.R., and Stern, M.J. (1995). An FGF receptor signaling pathway is required for the normal cell migrations of the sex myoblasts in C. elegans hermaphrodites. Cell 83, 611-620.
9. Ellis, L., Clauser, E., Morgan, D.O., Edery, M., Roth, R.A.,and Rutter, W.J. (1986). Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose. Cell 45, 721-732.
10. Evans, S.V. (1993). SETOR: Hardware lighted three-dimensional solid model representations of macromolecules. J. Mol. Graphics 11, 134-138.
11. Hendrickson, W.A. (1979). Transformations to optimize the superposition of similar structures. Acta Cryst. A35, 158-163.
12. Hubbard, S.R., Wei, L., Ellis, L., and Hendrickson, W.A. (1994). Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature. 372, 746-754.
13. Janin, J., and Chothia, C. (1990). The structure of protein - protein recognition sites. J. Biol. Chem. 265, 16027-16030.
14. Jaye, M., Schlessinger, J., and Dionne, C.A. (1992). Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transduction. Biochem. Biophys. Acta 1135, 185-199.
15. Johnson, L.N., Noble, M.E.M., and Owen, D.J. (1996). Active and inactive protein kinases: structural basis for regulation. Cell 85, 149-158.
16. Jones, T.A. (1985). Diffraction methods for biological macromolecules. Interactive computer graphics: FRODO. Methods Enzymol. 115, 157-171.
17. Kabsch, W., and Sander, C. (1983). Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 22, 2577-2637.
18. Kavanaugh, W.M., and Williams, L.T. (1994). An alternative to SH2 domains for binding tyrosine-phosphorylated proteins. Science 266, 1862-1865.
19. Klambt, C., Glazer, L., and Shilo, B.C. (1992). Breathless, a Drosophila FGF receptor homolog, is essential for migration of tracheal and specific midline glial cells. Genes Dev. 6, 1668-1678.
20. Knighton, D.R., Zheng, J., Ten Eyck, L.F., Ashford, V.A., Xuong, N.-H., Taylor, S.S., and Sowadski, J.M. (1991). Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science 253, 407-414.
21. Kraulis, P.J. (1991). MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24, 946-950.
22. Laskowski, R.A., MacArthur, M.W., Moss, D.S., and Thornton, J.M. (1993). PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26, 283-291.
23. Mohammadi, M., Dionne, C.A., Li, W., Li, N., Spivak, T., Honegger, A.M., Jaye, M., and Schlessinger, J. (1992). Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis without affecting mitogenesis. Nature 358, 681-684.
24. Mohammadi, M., Dikic, I., Sorokin, A., Burgess, W.H., Jaye, M., and Schlessinger, J. (1996). Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction. Mol. Cell. Biol. 16, 977-989.
25. Naski, M.C., Wang, Q., Xu, J., Ornitz, D.M., (1996). Graded activation of fibroblast growth factor receptors by mutations causing achondroplasiaand thanatophoric dysplasia. Nature Genet. 13, 233-237.
26. Navaza, J. (1994). AMoRe: an automated package for molecular replacement. Acta Crystallogr. A50, 157-163.
27. Nicholls, A., Sharp, K.A., and Honig, B. (1991). Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 11, 281-296.
28. Otwinowski, Z. (1991). Maximum likelihood refinement of heavy atom parameters. In Isomorphous Replacement and Anomalous Scattering, W. Wolf, P.R. Evans, and A.G.W. Leslie, eds. (Daresbury, United Kingdom: Daresbury Laboratory), pp. 80-86.
29. Otwinowski, Z. (1993). Oscillation data reduction program. In Proceedings of the CCP4 Study Weekend, L. Sawyer, N. Isaacs, and S. Burley, eds. (Daresbury, United Kingdom: SERC Daresbury Laboratory), pp. 56-62.
30. Pawson, T., and Schlessinger, J. (1993). SH2 and SH3 domains. Current Biol. 3, 434-442.
31. 2+ flux but not mitogenesis. Nature 358, 678-781.
32. Schlessinger, J., Lax, I., and Lemmon, M. (1995). Regulation of growth factor activation by proteoglycans: what is the role of the low affinity receptors? Cell 83, 357-360.
33. Tavormina, P.L., Shiang, R., Thompson, L.M., Zhu, Y.Z., Wilkin, D.J., Lachman, R.S., Wilcox, W.R., Rimoin, D.L., Cohn, D.H., and Wasmuth, J.J. (1995). Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nature Genet. 9, 321-328.
34. Taylor, S.S., Radzio-Andzelm, E., and Hunter, T. (1995). How do protein kinases discriminate between serine/threonine and tyrosine? Stuctural insights from the insulin receptor protein-tyrosine kinase. FASEB J. 9, 1255-1266.
35. Ullrich, A., and Schlessinger, J. (1990). Signal transduction by receptors with tyrosine kinase activity. Cell 61, 203-212.
36. Zhang, F., Strand, A., Robbins, D., Cobb, M.H., and Goldsmith, E.J. (1994). Atomic structure of the MAP kinase ERK2 at 2.3 Å resolution. Nature 367, 704-711.
37. Zheng, J., Knighton, D.R., Ten Eyck, L.F., Karlsson, R.K., Xuong, N.-H., Taylor, S.S., and Sowadski, J.M. (1993). Crystal structure of the catalytic subunit of cAMP-dependent protein kinase complexed with MgATP and peptide inhibitor. Biochem. 32, 2154-2161.